Daniel Griffin's clinical update: tecovirimat fails for MPOX, measles surges past 1,000 cases, vaccine policy ignores data.
No. The STOMP phase three trial, published in the New England Journal of Medicine with Jason Zucker as first author, randomized 412 participants two-to-one. By day 29 clinical resolution was 83% with tecovirimat versus 84% with placebo, with no substantial difference in pain reduction, lesion healing or viral DNA clearance.
Answered around 10:28Over a thousand confirmed cases in the first two months of the year, putting the country on track for more than 6,000. The Johns Hopkins tracker, which runs behind, is almost at 1,200. South Carolina alone had 990 confirmed cases as of March 3rd, and Utah is up to 358.
Answered around 12:39A MedArchive preprint estimated the 2025 cost per measles case at $104,629, a national burden of $244 million. At roughly 6,000 cases the total approaches a billion dollars. Costs were highest in Arizona, California and Texas, lowest in Maine, with a cumulative $7.77 billion over five years.
Answered around 13:07Infected unvaccinated children are 2.7 times more likely to be hospitalized and three times more likely to get a prescription anti-infective, with risk 22% higher for the rest of the year. Measles also brings ear infections, diarrhea, 20% hospitalization, 5% pneumonia, one in a thousand brain swelling.
Answered around 16:57No. In a double-blind randomized trial at two tertiary hospitals in South Korea, 396 adults with a PASC score of 12 or greater got metformin up to 1500 mg daily, UDCA 900 mg daily, or placebo for 14 days. Recovery was 63.6%, 68% and 68% respectively.
Answered around 32:04Yes. Measles is back, so anyone who is an 80s kid and received only the single MMR dose is advised to go ahead and get that second shot. The second dose provides a little more protection and seems to help substantially at a population level as well.
Answered around 40:43Pre-bunking teaches people to recognize falsehoods before they encounter them, instead of exhausting whack-a-mole on individual claims. The Science Advances article Psychological Inoculation Improves Resilience Against Misinformation on Social Media covered seven high-powered pre-registered studies, including a YouTube field experiment, with nearly 30,000 participants total.
Answered around 4:22The WHO recommended completely changing all three viral strains for the northern hemisphere's next season, including the new H3N2 subclade K variant that rose last fall. Egg-based vaccines carry an influenza B Tokyo, cell culture, recombinant protein and nucleic acid vaccines an influenza B Pennsylvania, both Victoria lineage.
Answered around 23:35Yes. UC Davis confirmed highly pathogenic avian influenza in seven northern elephant seals, the first H5N1 detection in marine animals in California. The seals lived at the Ano Nuevo reserve near Santa Cruz, a park home to 5,000 seals in winter; 1,350 were on the beach when the outbreak began.
Answered around 11:32Not yet. Boosters and their possible benefits have been looked at, but there is still no booster recommendation for RSV vaccination. It was not clear that a second shot would give any real advantage at this point. After one shot, wait until more is known.
Answered around 34:14“Yeah, no, I think this just takes tecovirumab off the table.”
“So, yeah, I think, you know, it's unfortunate because now we have no treatment, no effective treatment for MPOX.”
“So this scenario would result in a cumulative cost of $7.77 billion over five years.”
“It's quite clear we lost the status.”
“So it's coming from an ideological stance.”
“I mean, we had over a thousand children die in the U.S. from COVID.”
“Pre-Bunking Misinformation.” https://traffic.libsyn.com/secure/twiv/TWiV1302.mp3. Transcript summary by WhipScribe, https://whipscribe.com/transcript-pages/pre-bunking-misinformation.html.